We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Early-Life Body Adiposity and the Breast Tumor Transcriptome.
- Authors
Wang, Jun; Peng, Cheng; Guranich, Catherine; Heng, Yujing J; Baker, Gabrielle M; Rubadue, Christopher A; Glass, Kimberly; Eliassen, A Heather; Tamimi, Rulla M; Polyak, Kornelia; Hankinson, Susan; Askew, Catherine
- Abstract
<bold>Background: </bold>Cumulative epidemiologic evidence has shown that early-life adiposity is strongly inversely associated with breast cancer risk throughout life, independent of adult obesity. However, the molecular mechanisms remain poorly understood.<bold>Methods: </bold>We assessed the association of early-life adiposity, defined as self-reported body size during ages 10-20 years from a validated 9-level pictogram, with the transcriptome of breast tumor (N = 835) and tumor-adjacent histologically normal tissue (N = 663) in the Nurses' Health Study. We conducted multivariable linear regression analysis to identify differentially expressed genes in tumor and tumor-adjacent tissue, respectively. Molecular pathway analysis using Hallmark gene sets (N = 50) was further performed to gain biological insights. Analysis was stratified by tumor estrogen receptor (ER) protein expression status (n = 673 for ER+ and 162 for ER- tumors).<bold>Results: </bold>No gene was statistically significantly differentially expressed by early-life body size after multiple comparison adjustment. However, pathway analysis revealed several statistically significantly (false discovery rate < 0.05) upregulated or downregulated gene sets. In stratified analyses by tumor ER status, larger body size during ages 10-20 years was associated with decreased cellular proliferation pathways, including MYC target genes, in both ER+ and ER- tumors. In ER+ tumors, larger body size was also associated with upregulation in genes involved in TNFα/NFkB signaling. In ER- tumors, larger body size was additionally associated with downregulation in genes involved in interferon α and interferon γ immune response and Phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) signaling; the INFγ response pathway was also downregulated in ER- tumor-adjacent tissue, though at borderline statistical significance (false discovery rate = 0.1).<bold>Conclusions: </bold>These findings provide new insights into the biological and pathological underpinnings of the early-life adiposity and breast cancer association.
- Subjects
BREAST tumors; CIRCULAR RNA; PHOSPHATIDYLINOSITOL 3-kinases; MYC oncogenes; FALSE discovery rate; OBESITY; CANCER relapse; RESEARCH; PHOSPHOTRANSFERASES; RESEARCH methodology; EVALUATION research; COMPARATIVE studies; GENE expression profiling; CENTER for Epidemiologic Studies Depression Scale; RESEARCH funding; ADIPOSE tissues
- Publication
JNCI: Journal of the National Cancer Institute, 2021, Vol 113, Issue 6, p778
- ISSN
0027-8874
- Publication type
journal article
- DOI
10.1093/jnci/djaa169